{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:04:47Z","timestamp":1790143487867,"version":"4.0.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059107","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T22:00:56Z","timestamp":1362780056000},"page":"e59107","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Sanne","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian T.","family":"ten Kate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjo J.","family":"de Knegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri A.","family":"Verbrugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Nouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma A. J. M.","family":"Bakker-Woudenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"<italic>Staphylococcus aureus<\/italic> infections","volume":"339","author":"FD Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant <italic>Staphylococcus aureus<\/italic> infections in the United States","volume":"298","author":"RM Klevens","year":"2007","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.CCM.0000239121.09533.09","article-title":"Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database","volume":"34","author":"AF Shorr","year":"2006","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"MM Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","article-title":"Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein","volume":"34","author":"MB Pepys","year":"1983","journal-title":"Adv Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2298\/VSP1011893L","article-title":"Kinetics of C-reactive protein, interleukin-6 and -10, and phospholipase A2-II in severely traumatized septic patients","volume":"67","author":"Z Lausevic","year":"2010","journal-title":"Vojnosanit Pregl"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"MB Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI116336","article-title":"Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease","volume":"91","author":"DM Vigushin","year":"1993","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","article-title":"Pathobiochemistry and clinical use of procalcitonin","volume":"323","author":"M Meisner","year":"2002","journal-title":"Clin Chim Acta"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.3895437","article-title":"Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin","volume":"229","author":"B Beutler","year":"1985","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI113540","article-title":"Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits","volume":"81","author":"JC Mathison","year":"1988","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/348550a0","article-title":"Interleukin-1 receptor antagonist reduces mortality from endotoxin shock","volume":"348","author":"K Ohlsson","year":"1990","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"KJ Tracey","year":"1987","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fasebj.5.3.1825816","article-title":"A specific receptor antagonist for interleukin 1 prevents <italic>Escherichia coli<\/italic>-induced shock in rabbits","volume":"5","author":"G Wakabayashi","year":"1991","journal-title":"FASEB J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group","volume":"273","author":"E Abraham","year":"1995","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00003246-199609000-00002","article-title":"INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group","volume":"24","author":"J Cohen","year":"1996","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"CJ Fisher Jr","year":"1994","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003246-199401000-00008","article-title":"Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial","volume":"22","author":"CJ Fisher Jr","year":"1994","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"SM Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00003246-199605000-00003","article-title":"Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study","volume":"24","author":"K Reinhart","year":"1996","journal-title":"Crit Care Med"},{"key":"ref21","first-page":"1605","article-title":"Procalcitonin increase after endotoxin injection in normal subjects","volume":"79","author":"P Dandona","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/infdis\/175.1.118","article-title":"Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13","volume":"175","author":"T van der Poll","year":"1997","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/IAI.68.4.1942-1945.2000","article-title":"Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis","volume":"68","author":"F Arnalich","year":"2000","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/cc1843","article-title":"Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit","volume":"7","author":"IC Balc","year":"2003","journal-title":"Crit Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00024382-200115030-00003","article-title":"Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients","volume":"15","author":"G Mathiak","year":"2001","journal-title":"Shock"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1086\/314963","article-title":"Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock","volume":"180","author":"F Arnalich","year":"1999","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00003246-200005000-00003","article-title":"Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia","volume":"28","author":"SR Grobmyer","year":"2000","journal-title":"Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1111\/j.1365-2230.2009.03353.x","article-title":"Cytokine profile during the clinical course of toxic shock syndrome","volume":"34","author":"M Seishima","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1086\/314839","article-title":"Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock","volume":"180","author":"J Cohen","year":"1999","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"CA Gogos","year":"2000","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/pmic.200900313","article-title":"Proteomics uncovers extreme heterogeneity in the <italic>Staphylococcus aureus<\/italic> exoproteome due to genomic plasticity and variant gene regulation","volume":"10","author":"AK Ziebandt","year":"2010","journal-title":"Proteomics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2010.12.013","article-title":"A multiplex assay for the quantification of antibody responses in <italic>Staphylococcus aureus<\/italic> infections in mice","volume":"365","author":"S van den Berg","year":"2011","journal-title":"J Immunol Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/039463200902200318","article-title":"Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice","volume":"22","author":"JE De Steenwinkel","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref34","unstructured":"Reichelt ME, Ashton KJ, Tan XL, Mustafa SJ, Ledent C, <etal>et al<\/etal>.. (2011) The adenosine A(2A) receptor - Myocardial protectant and coronary target in endotoxemia. Int J Cardiol."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.4049\/jimmunol.154.11.6048","article-title":"Expression and biologic characterization of the murine chemokine KC","volume":"154","author":"CR Bozic","year":"1995","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.09-135467","article-title":"Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues","volume":"23","author":"AG Cheng","year":"2009","journal-title":"FASEB J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"L633","DOI":"10.1152\/ajplung.00231.2004","article-title":"Anti-inflammatory response is associated with mortality and severity of infection in sepsis","volume":"288","author":"A Ashare","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.179.1.623","article-title":"Chronic sepsis mortality characterized by an individualized inflammatory response","volume":"179","author":"MF Osuchowski","year":"2007","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e26928","DOI":"10.1371\/journal.pone.0026928","article-title":"Platelet and neutrophil responses to gram positive pathogens in patients with bacteremic infection","volume":"6","author":"D Johansson","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T01:19:40Z","timestamp":1688087980000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059107"}},"subtitle":[],"editor":[{"given":"Stephania Ann","family":"Cormier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059107","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}